Members of the Lactobacillus genus are frequently utilized in the probiotic industry with many species 13 conferring demonstrated health benefits; however, these effects are largely strain-dependent. We 14 designed a method called PROTEAN (Probabilistic Reconstruction Of constituent Anabolic Networks) to 15 computationally analyze the genomic annotations and predicted metabolic production capabilities of 16 144 strains across 16 species of Lactobacillus isolated from human intestinal, oral, and vaginal body 17 sites. Using PROTEAN we conducted a genome-scale metabolic network comparison between strains, 18
Introduction 43
Lactobacillus is a diverse genus of bacteria with many member strains associated with the human body. 44 Lactobacilli are Gram-positive, lactic acid-producing bacteria typically with a low GC content (1, 2) . They 45 are known for their production of lactic acid, being facultative anaerobes, and are capable of being 46 metabolically active in a large variety of conditions (3). There is evidence that human-associated 47 lactobacilli colonize mucosal surfaces of the intestinal tract (4), vagina (5-12), and oral cavity (13, 14) . 48 While strains of Lactobacillus have been isolated from all three of these body sites, it remains unknown 49
which are permanent members of the resident microbiota (autochthonous) opposed to transient 50 members (allochthonous). Transient intestinal lactobacilli are either resident members of the oral 51 microbiota or have been ingested, most commonly from unpasteurized fermented foods (4,15). 52
Lactobacilli have been used for a broad range of applications primarily associated with human intestinal 53 probiotics and industrial production of useful metabolites. Lactobacillus-based probiotics have been 54
shown to confer health benefits in clinical studies for a variety of conditions including prevention of 55 antibiotic associated diarrhea (16), Clostridium difficile-associated diarrhea (17), constipation (18), 56 irritable bowel syndrome (19), and eczema/atopic dermatitis (20) . Probiotics are controversial, likely due 57 to claims made by currently marketed probiotics that lack FDA approval for the treatment of specific 58 diseases (21, 22) . The primary benefits associated with lactobacilli-based probiotics may be a function of 59 their presence in the gut, production of metabolites, and modulation of the immune system (23,24). 60
Metabolism plays a key role in all three of these general mechanisms; therefore, a better understanding 61 of their metabolic capabilities will help to elucidate the mechanisms contributing to probiotic effects 62 (25) . 63
In recent years, there has been an explosion of genomic and metagenomic sequencing of human-64 associated microbiota, which provides a unique opportunity to apply genome-scale metabolic network 65 reconstructions (GENREs) to enhance our current understanding of human-associated lactobacilli 66 metabolism utilizing in silico techniques (25) . Systems biology has the potential to advance design, 67 selection, and delivery of Lactobacillus-based probiotics (26, 27) . GENREs are a powerful computational 68 tool for mathematically modeling the metabolic processes within a cell at a systems-level, including all 69 known metabolic reactions, metabolites, and metabolic genes in an organism (28) . GENREs are created 70 by referencing an annotated genome against biochemical databases, then integrating experimental data 71 when available (29). There are several examples of Lactobacillus-specific comparative genomics studies 72 (30-35); however, GENREs allow for a more functional perspective than genomics data alone because of 73 the quantitative accounting for interactions between components in the network (25,36). Simulations 74
with GENREs can accurately predict microbial growth yields and the metabolic pathways utilized for the 75 production of metabolites during exponential growth of a microbe (37). A variety of analytical 76 approaches can be applied to interrogate emergent properties of a GENRE. Flux Balance Analysis (FBA) 77 and related methods have proven highly successful in the analysis of metabolic networks (38). FBA is a 78 mathematical technique for analyzing the flow of metabolites through a GENRE; it can be used to 79 identify a set of reaction fluxes that maximize growth in a specified media condition among other 80 applications (28, 39, 40) . Metabolic network reconstructions and FBA provide a mechanistic look into  81  cellular metabolism and are increasingly used to study biochemical processes of single bacterial species  82 as well as communities of organisms (41). 83
GENREs enable the computational prediction of metabolic capabilities of microbes, both catabolic and 84 anabolic. Additionally, GENREs are capable of contextualizing large 'omic datasets (i.e. genomics, 85 transcriptomics, and metabolomics) with known biochemistry and biological network architectures for 86 improved understanding of the experimental data (42). An important recent finding demonstrated that 87 metabolomics data alone can be used to differentiate between bacterial cultures at the strain level (43). 88 We developed a computational method using GENREs to predict the metabolic products that a strain is 89 likely able to produce. We used predicted production capabilities to then differentiate between 90 different human-associated Lactobacillus strains. Just as metabolomics data can be used to differentiate 91 bacterial strains, predicted production capabilities can be used for the same comparisons. We assessed 92 the metabolic potential across a broad set of Lactobacillus species, consisting of 144 strains, which have 93 all been isolated from three human-related body sites: intestinal, oral, and vaginal. We found that 94
intestinal and oral isolates have a great deal of overlap in their metabolic functionality, while vaginal 95
isolates have more unique metabolic production capabilities. These analyses can facilitate additional 96 experimental interrogation of this important genus of bacteria. 97
Results and Discussion

98
Annotated metabolic genes associated with known metabolic functions are sufficiently represented 99 among human-associated lactobacilli 100
In this study we predict the metabolic production capabilities of 144 lactobacilli strains. We utilized the 101 PATRIC Cross-Genus Protein Families (PGfams) (4) for an initial genomic analysis. PGfams are 102 comparable clusters of proteins that likely have similar functions. These clusters are intended to be used 103 for cross-genus comparison due to their slightly relaxed clustering criteria. However, PGfams allow for 104 the comparison of the large number of strains analyzed in this study. Lactobacilli consist of a broad 105 range of species and thus using the PGfams was appropriate for an initial genomic comparison in this 106 study. We first filtered the PGfams to only include metabolic gene families associated with known 107 metabolic functions (see Methods). The distribution of total metabolic PGfams associated with each 108 genome ranges from 340 to 580 and has a median value of 515 ( Figure 1A ). Across these 144 strains we 109 found that they share 116 core metabolic PGfams, spanning a variety of cellular functions including, but 110 not limited to, carbohydrate, nucleotide, and amino acid metabolism (Table S1 ). The pan set of 111 metabolic PGfams, which represents the total set of unique PGfams, expanded to over 1500 after 112 considering all strains utilized within this study ( Figure 1B) . The Lactobacillus strains we studied 113 consisted of 16 species and were isolated from intestinal, oral, and vaginal human body sites ( Figure 1C ). 114 (Table   125   S2 ).
126
Probabilistic Reconstruction Of constituent Anabolic Networks (PROTEAN) 127
We developed PROTEAN to predict the metabolic production capabilities of microbes based on genomic 128 data alone. PROTEAN generates constituent metabolic production networks with maximum parsimony 129 and probability to predict the production of a given metabolite with a defined set of input metabolites. 130
PROTEAN is a combination of well-validated methods, including Parsimonious Enzyme Usage Flux 131
Balance Analysis (pFBA) (37), likelihood-based gap filling (44), fastGapFill (45), and CarveMe (46). The 132 algorithm uses the ModelSEED biochemical reaction database, a large set of known metabolic reactions, 133
for constituent network generation (47). First, reaction likelihoods are calculated for each reaction in the 134
ModelSEED database using Probannopy (48) ( Figure 2 ). Reaction likelihoods correspond to the 135 probability that a given reaction is catalyzed by an enzyme that is encoded for by the genome. We 136 modified pFBA to utilize reaction likelihoods for weighted minimization of flux through each reaction, 137
while still maintaining near-optimal flux through the objective function. Standard pFBA assumes that 138 metabolism is optimized to minimize enzymatic turnover and thus the method is driven by a 139 minimization of the total flux through the metabolic network (37). Weighted pFBA allows for the 140 reconstruction of constituent anabolic networks while accounting for maximum genomic probability and 141 resource parsimony (see Methods). The constituent anabolic networks output by PROTEAN consist of 142 flux-carrying reactions required for the production of a certain metabolite with preferential flux through 143 reactions that have higher reaction likelihoods. A constituent network represents a theoretically optimal 144 biosynthetic network while accounting for the greatest genomic evidence for production of a given 145 metabolite in a set media condition (Table S4 ). We represent the information from each constituent 146 network using a single summary metric referred to as the Production Likelihood by calculating the 147 average of all likelihoods of reactions that carry flux. The average of all reaction likelihoods in a 148 metabolic pathway has been previously shown to be a valuable metric for making comparisons between 149 networks (44). 150 151 Figure 2: PROTEAN is an approach for quantifying the likelihood that a given metabolic network, derived 152 exclusively from genomic evidence, is capable of synthesizing a particular metabolite. A modified version of 153 Parsimonious Enzyme Usage FBA (weighted pFBA) was performed on a standardized set of reactions to generate 154 constituent anabolic networks for each genome. Reaction likelihoods were used to weight the minimization of flux 155 through each reaction in the network. Therefore, reactions with a greater likelihood were more likely to be 156 included in the resulting constituent anabolic network. Each constituent network has a set of input metabolites 157 representing the media condition (Table S4 ) and a demand reaction for a certain metabolic product. The resulting 158 constituent network is the set of reactions that requires flux to produce the metabolic product in the given media 159 condition. The production likelihood metric is an average of all the reaction likelihoods associated with the 160 reactions included in the constituent network. This metric is used as a summary statistic that allows for the 161 comparison of constituent networks across different metabolic products and strains, where a higher production 162 likelihood corresponds with greater genetic evidence for that particular constituent anabolic network.
163
The Scaled Production Likelihood metric facilitates comparison of anabolic capabilities between 164 species and strains 165 Predicted constituent anabolic networks were generated for a set of 50 biologically-relevant metabolic 166 products for each of the 144 Lactobacillus strains. The 50 metabolites were selected based on known 167
Lactobacillus biology (see Methods). For each metabolic product, we generated a constituent anabolic 168 network (Table S3 ) across all strains. For each genome we scaled the Production Likelihoods metric by 169
calculating the corresponding z-score. The standard deviation for the z-score calculation was across all 170 metabolic products for each strain. This metric allows for a relative comparison of production 171 capabilities across strains that does not rely on well-curated metabolic network reconstructions. The 172
resulting Scaled Production Likelihood (SPL) is a metric indicating likelihood that a genome encodes for 173 the cellular machinery required to produce a metabolite, given a specific media condition, relative to all 174 of the other SPLs for the metabolic products per strain. For visualization, these data were grouped by 175 species and summarized using the median of the SPLs across all of the strains within each species ( Figure  176 3). 177 
184
The strains were grouped by species and clustered based on median SPLs. We found that across the 16 185 species, D-and L-lactate both have high median SPLs, as we would expect with lactobacilli. Additionally, 186 fumarate and GABA have particularly low SPLs across all species. We were able to find several 187 publications indicating GABA can be produced by select lactobacilli in specific environments (49,50). 188
However, we were unable to find publications discussing the production of fumarate by lactobacilli. 189
Additionally, we found that the dendrogram from clustering based on predicted metabolic production 190 capabilities does not qualitatively align well with published phylogenetic trees generated using the 16S 191 rRNA gene (34). The misalignment to established phylogenetic trees indicates that phylogeny is a poor 192 indicator of metabolic production capabilities. It is likely that evolution of metabolic production 193 capabilities is driven independently from classical genes used for phylogenetic comparisons, such as the 194 16S rRNA gene. Therefore, we need more precise computational tools to better understand the 195 phenotypic differences between microbial species when interrogating metabolism. Perhaps 196 phylogenetic analysis would be augmented with the consideration of metabolic genes in addition to the 197 16S rRNA gene. 198
Intestinal and oral Lactobacillus strains have different metabolic capabilities compared to vaginal 199 strains 200
We performed principle coordinate analysis (PCoA) on the SPLs for each species and determined that 201
the Lactobacillus strains cluster significantly by both species (Figure 4A ) and isolation site ( Figure 4B ) 202 (PERMANOVA; P < 0.001). The vaginal isolates differ from both the oral and gut cluster ( Figure 4B ). 203
Substantial overlap was found between oral and gut isolates, specifically within L. gasseri, L. rhamnosus, 204
and L. salivarius, likely due to the consistent transmission of orally colonized microbes to the intestines 205 (15). It has been hypothesized that many of the lactobacilli isolated from the gut are actually transient 206 strains that are colonized in the oral cavity (51). Our data supports this hypothesis by showing that oral 207 isolates are metabolically similar to a portion of the intestinal isolates. However, there are lactobacilli, 208 such as L. reuteri, which likely colonize the human intestines (52). Five of the 16 species in this study are 209 only represented by strains isolated from the intestines; although this result is influenced by sampling 210 bias in the PATRIC Database, it provides support that our data contains species that are only found in 211 the intestines. The vaginal isolates cluster separately from the intestinal/oral isolates along the primary 212 coordinate that accounts for 78% of the variation in these data. The vaginal microbiota is frequently 213 dominated by several Lactobacillus species, such as L. iners, L. crispatus, and L. jensenii (53-55). This 214 separation of vaginal isolates from intestinal/oral isolates indicates that these two main clusters have 215 differences in their metabolic production capabilities. This result is to be expected because the 216 intestinal/oral nutrient environment is drastically different from the vaginal environment and the 217 dominant species appear to have metabolic capabilities that reflect this difference. 218 
223
In addition to distinguishing isolates by body site, the SPL metric is capable of defining collections of 224 functional components that drive differences between groups. Using standard genomic analyses, 225 differences between groups are typically defined by the differential gene content. Genes are intrinsically 226 part of a larger network of metabolism where absence of specific functionality related to a gene may be 227 compensated for within the system. Since our approach is based on Production Likelihoods of specific 228 metabolites, it functions within a more complex metabolic framework compared to the analysis of 229 genomic data without the network context. Using machine learning, we were able to identify the set of 230 metabolites for which each group of strains is more likely to encode the cellular machinery required for 231 production. We conducted a machine learning feature selection to determine the metabolites that are 232 most likely to be produced by each group of strains, intestinal/oral strains and vaginal strains. We 233 grouped the intestinal and oral strains together due to their inherent similarity ( Figure 4B ) and the 234 observed transmission of oral strains to the intestines (15,51). We generated two separate area under 235 the curve random forest (AUCRF) models to determine the metabolites that were more likely to be 236 produced by each of the groups. Two models were necessary to enrich for the most discriminatory 237 metabolites that were more likely to be produced in each of the groups, rather than simply identifying 238 the metabolites that best classify the samples based on isolation site regardless of being more or less 239 likely to be produced (See methods). The first model was generated to select the metabolites that are 240 most likely to be produced by the intestinal and oral isolates compared to the vaginal isolates, while 241 maximally discriminating the groups. The eight metabolites selected accurately classify greater than 90% 242 of isolates to the correct group ( Figure 5A ). The second model was generated to select the metabolites 243 that are most likely to be produced by the vaginal isolates compared to the intestinal and oral isolates, 244
while maximally discriminating the groups. The seven metabolites selected accurately classify greater 245 than 90% of the isolates to the correct group ( Figure 5B ). 246 
254
Using SPLs as an input for AUCRF feature selection, we identified the metabolites that are most likely to 255 be produced by the strains associated with the two isolate groups, intestinal/oral and vaginal. The 256 selected metabolite products may contribute to how the strains interact with the mucosal tissues in 257 each site. We hypothesize that these metabolites are related to key phenotypic differences between the 258 two isolate groups. Four of the selected metabolites that are likely produced by intestinal/oral strains, 259 D-alanine, D/L-serine, and L-proline ( Figure 5A) , have all been previously identified to have an impact on 260 the human intestinal epithelium (23,24,56-58). Additionally, four of the selected metabolites that are 261 likely produced by vaginal strains, L-arginine, citrulline, and D/L-lactate ( Figure 5B) , have been previously 262
identified to have an impact on the human vaginal microbiome (59-62). The metabolites for which we 263
have not found existing experimental evidence for are likely worth focusing on in future experimental 264 studies. 265
For intestine-associated lactobacilli in this study, there is a connection between intestinal immune 266 system regulation and D-alanine rich lipotechoic acid, a glycolipid expressed by some lactobacilli, such as 267 L. plantarum (23,24). D-alanine rich lipotechoic acid, produced by lactobacilli, has been shown to down-268 regulate local colonic inflammation in a murine colitis model (23, 24) . With PROTEAN we identified that 269
intestinal lactobacilli were more likely to produce D-alanine ( Figure 5A ). It is possible that a positive 270 interaction with the intestinal host immune system would result in an evolutionary advantage by 271 reducing local immune response. Additionally, serine rich serine-threonine peptides have been shown to 272 have a similar regulatory effect on intestinal dendritic cells (56,57). These peptides expressed by L. 273
plantarum are resistant to intestinal proteolysis and appear to be present in the colon of most healthy 274 individuals (56,57). Similar to D-alanine, the production of D/L-serine would require a robust 275 biosynthesis pathway present in those strains. 276
A final gut-related connection involves the biosynthesis of L-proline ( Figure 5A) . One of the primary 277 stress responses in L. acidophilus to high osmotic pressure results in the accumulation of L-proline in the 278 cell; there is little evidence that this response is a result of L-proline transport into the cell (58). These 279
Lactobacillus strains are exposed to a large range of stressors in the gut, including suboptimal osmotic 280
pressures. There is strong evidence that L-proline is used by L. acidophilus to tolerate suboptimal 281 osmotic pressures and there is a lack of evidence for L-proline transporters. As such, the biosynthesis of 282 L-proline may be advantageous for growth in the gut. 283
For the enriched metabolic products in vaginal isolates ( Figure 5B ), there is evidence for an 284 arginine/ornithine antiporter and arginine deiminase in L. fermentum (59). These enzymes are part of 285 the arginine deiminase pathway through which there is the production of citrulline which is exported 286 from the cell and contributes to acid tolerance (59). It has also been demonstrated that treatment with 287 probiotics containing arginine deiminase-positive lactobacilli can improve clinical symptoms of vaginosis 288
in parallel with significant declines in polyamine (i.e. arginine, ornithine, and citrulline) levels in the 289 vagina (60,61). The vaginal isolates in this study show enrichment for the cellular machinery required for 290 the production of both citrulline and L-arginine ( Figure 5B ). The importance of lactate for the adequate 291 maintenance of vaginal health in many individuals is known. The current hypothesis revolves around 292 colonization resistance where vaginal lactobacilli establish an acidic environment by producing lactate 293 (62). The acidic environment is generally inhospitable to invading pathogens as well as other microbes 294 that are otherwise capable of residing in the vaginal environment (62). It has been shown that higher 295 levels of D-lactate over L-lactate present in the vagina, produced by lactobacilli, further decrease the 296 chance of infections in female patients (62). However, both isoforms of lactate remain important in 297 maintaining vaginal health. 298
Conclusions 299
Microbial biosynthesis of metabolites has a broad range of applications, from bio-manufacturing to 300 microbiome research (63). There is a wealth of well-curated and accessible knowledge stored in 301
biochemical reaction databases such as ModelSEED (64). Genome-Scale Metabolic Network 302
Reconstructions access this fundamental knowledge while accounting for systems-level interactions. 303
This study represents one such application of GENREs that is a step toward predicting the metabolic 304 production capabilities of understudied organisms. Experimental validation of the production 305 capabilities predicted with PROTEAN will allow for conclusions to be made beyond the statement that a 306 microbe is genetically likely to be able to produce a metabolite. Utilizing PROTEAN data, we found that 307 human-associated lactobacilli strains cluster significantly by species and isolation site. Additionally, 308 many of the metabolic products that drive the clustering of strains by the isolation sites have known 309 physiological function and importance in the respective isolation sites. 310
Future applications of PROTEAN could include optimal strain selection for bio-manufacturing of a certain 311 compound, generating predicted metabolomics data for an organism to generate a prioritized list of 312 conditions that would be most worthwhile to validate experimentally, and predicting the metabolites 313
that are most likely to be produced in a microbiota. Microbes can have a wide range of physiological 314 impacts on human health; these impacts are, in part, a result of the metabolites that are or are not 315 produced by members of a microbiota. One of the core limitations of this study includes the lack of 316 reaction likelihoods for some reactions in the universal reaction bag we used from ModelSEED. The 317 number of reactions we could generate likelihoods for was limited by the Probannopy reaction 318 template. However, this template can be expanded to continue to improve the utility of PROTEAN. With 319 the inclusion of validation data, additional analyses will be possible, such as determining metabolic 320 production pathways lacking proper annotation. By determining the reactions that are most likely 321 required for biosynthesis of a known product, it would be possible to generate additional hypotheses for 322 enzyme annotation experiments. PROTEAN is an algorithm with potential for a wide range of 323 applications in the study and use of microbial metabolic networks. 324
Methods
325
Constituent Anabolic Network Generation (PROTEAN) 326
Probabilistic pFBA-based constituent anabolic network generation was accomplished using three Python 327 packages, Cobrapy (65), Mackinac (66), and Probannopy (48). The complete ModelSEED universal 328 reaction bag was downloaded from the github repository and filtered based on the annotation quality 329 score, including all reactions with an 'OK' quality status or better (64). For each reaction in the 330
ModelSEED universal reaction bag, we used Probannopy to generate a reaction likelihood based on the 331 FASTA file for each genome obtained from the PATRIC database (4). The Cobrapy implementation of 332
Parsimonious Enzyme Usage Flux Balance Analysis (pFBA) was altered to allow for each reaction's linear 333 constraint to be set individually based on the reaction likelihood. The linear constraint for each reaction 334 was set to one minus the reaction likelihood (a value between 0 and 1). There were reactions included in 335 the universal reaction bag that were lacking from the Probannopy template model, therefore resulting 336
in several gene-associated reactions lacking reaction likelihood scores. The reactions without likelihoods 337
were left at a full minimization penalty (linear constraint value of 1). We chose to penalize the reactions 338 without likelihoods to bias our results towards the construction of networks for which all reactions had 339 evidence of presence. The linear constraints applied to each reaction based on likelihood acted as a 340
weighting (inclusion penalty) for the minimization step in pFBA, resulting in the reactions with greater 341 likelihood having a lower penalty for carrying flux; therefore, the reactions had a higher likelihood of 342 being included in the constituent anabolic networks. 343
Using PROTEAN, we generated constituent anabolic networks by setting a certain input media condition 344 (Table S4 ) and constraining flux through the single metabolite objective function (Table S3 ). We ran our 345 likelihood-weighted pFBA flux minimization across the entire universal reaction bag and isolated the 346 reactions that carried flux to get the desired product. The resulting networks consist of the direct 347 reactions that would be part of a production pathway as might be shown in a typical biosynthesis 348 pathway figure, while also accounting for all of the secondary and energy metabolites that are required 349 for the production of the metabolite in consideration. Additionally, this algorithm is optimizing for three 350 core characteristics in the constituent networks: 1) minimum flux through the network (loosely, the 351 minimum number of reactions), 2) maximum average reaction likelihood across the constituent 352 network, and 3) output flux within 90% of the optimal yield of the metabolic product. We chose to allow 353 flux through any reaction in the universal reaction bag during the generation of the constituent anabolic 354 production pathways rather than simply pulling from a GENRE that was first gapfilled to allow 355 production of biomass. Using the universal reaction bag instead of a gapfilled model was important 356 because the biomass function is difficult to define for understudied organisms and unnecessary for our 357 applications. 358
Scaled Production Likelihood Metric 359
We represent the information from each constituent network using a single summary metric for ease of 360 comparison, simply named the Production Likelihood. This metric is the average of the reaction 361 likelihoods included in the constituent network. The average reaction likelihood for a metabolic pathway 362 has been previously used for making comparisons between networks (44). The Production Likelihoods 363 for all 50 metabolites are scaled for each given genome by calculating the z-score to create the Scaled 364
Production Likelihoods used for the majority of the analysis in this study. The z-score is calculated for 365 each individual strain using the median and standard deviation for the production likelihoods across the 366 50 metabolic products. The Scaled Production Likelihood allows for a ranked comparison of metabolic 367 products across the genome set and corrects for annotation bias by essentially comparing the ranked z-368 score for each metabolic product. 369
Supporting data for pathway generation 370
The simulated media formulation was based on in vitro minimal media growth conditions for L. 371
plantarum (Table S4 ) (67-69). The techniques used in this study do not assume that all species are 372 capable of growth in the given media condition, therefore this media condition simply provides a 373 standard reference for comparison. The product list was developed by identifying metabolites that have 374 been shown to be produced by lactobacilli during in vitro growth experiments, in addition to other 375 metabolites that have been shown to be related to human physiology (70-74). 376
Machine learning feature selection 377
Discriminating intestinal/oral and vaginal features were selected using area under the ROC curve 378 random forest (AUCRF) using default parameters (75) (see Code). We generated two separate AUCRF 379 models to determine the metabolites that were more likely to be produced by each of the groups, 380
intestinal/oral and vaginal. Two models allowed us to enrich for likely products rather than simply 381 selecting for the metabolites that provide the greatest discrimination between the groups but which 382 may have poor likelihood scores. We conducted the enrichment for likely metabolic products for each 383 model by reducing the feature set down to only metabolites that were more likely to be produced by 384 the group of interest. Likely metabolic products were determined by comparing the median SPLs of each 385 metabolite between the groups. Additionally, the feature sets were reduced to include only metabolites 386 with a median value greater than zero for the group of interest. An AUCRF model was then generated to 387 select the features that provided the greatest discrimination between the two groups. 388
Statistical modeling and figure generation 389
The principle coordinate analysis (PCoA) ordinations were created using the R vegan package (76), 390
implemented with the Bray-Curtis dissimilarity metric. Statistical significance for comparing the PCoA 391 clusters was determined using a PERMANOVA (R Adonis test). A variety of R packages were used for all 392 figure generation (77-81). 393
Genome Quality and PATRIC Cross Genus Protein Family Data 394
Genomes used in the study were filtered for quality before being included in the analysis. Strains with 395 greater than 0.2% unknown nucleotide calls in the genome were eliminated. Low quality genome 396 assemblies with greater than 300 contigs were removed. Non-human associated Lactobacillus strains 397 from the PATRIC database were used to determine the GC content range for each species (82,83), and 398 significant outliers (plus or minus two percent) were removed to control for sequencing bias (84,85). 399
Only isolates from the three human-associated sites (oral, intestinal, and vaginal) were included in the 400 final dataset. 401
The inclusion of metabolic PATRIC cross genus protein families was conducted by filtering the PGfams 402
for each genome based on the existence of an associated known reaction and Probannopy likelihood 403 greater than 0. Pan and core metabolic PGfam sets were evaluated after the addition of all genomic 404
features from each genome. The pan set of metabolic PGfams was defined as the total number of 405 unique PGfams included in the data set after the above filtering steps. The core set of metabolic PGfams 406 are those that existed within each genome included in this study. 407
Data and code availability 408
Genome FASTA files and metadata were downloaded from the PATRIC Database (4). Python and R code 409 is available at: Github.com/Tjmoutinho/Lactobacillus 410
